Home Tools
Log in
Cart

Search Result

Search Results for " crc "

20

Compounds

Cat No. Product Name Synonyms Targets
T6212 Combretastatin A4 CA4,CRC 87-09 Microtubule Associated
Combretastatin A4 (CA4) is a microtubule-targeting agent that binds β-tubulin (Kd: 0.4 μM).
T10309 Amphethinile Amphetinile,CRC 82-07 Others
Amphethinile is an anti-tubulin agent. The Ka of Amphethinile with tubulin is 1.3 μM.
T29168 XR-5000 NSC-601316,CRC8805,SN-22995,DACA,CRC-8805
XR-5000 is a DNA topoisomerase I and II inhibitor.
T3055 Liensinine Perchlorate Apoptosis , Others
Liensinine is the active constituent of plumula nelambinis with anti-hypertension.
T40254 MRTX-1719 Histone Methyltransferase
MRTX-1719 is a potent, first-in-class, selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAP DEL SDMA cells.
T13176 TNO155 Batoprotafib Phosphatase
TNO155 is a protein tyrosine phosphatase (PTP) non-receptor type 11 (SHP2; src homology region 2 domain phosphatase; PTPN11) inhibitor(IC50 : 0.011 µM),with potential antineoplastic activity.
T0459 Sulindac Arthrocine,MK-231,Clinoril,Sulindac sulfoxide COX , Autophagy
Sulindac (Sulindac sulfoxide) is a sulfinylindene derivative prodrug with potential antineoplastic activity. Converted in vivo to an active metabolite, sulindac, a nonsteroidal anti-inflammatory drug (NSAID), blocks cycl...
T82324 GGASCCLYCRCH
GGASCCLYCRCH is a bioactive peptide that can inhibit the 2-O-methyltransferase activity within the SARS-CoV nsp16/10 complex.
T73593 PDS-0330 Others
PDS-0330 is a claudin-1 small molecule inhibitor inhibitor.PDS-0330 inhibits claudin-1-dependent CRC progression and binds directly and specifically to claudin-1 with micromolar affinity.PDS-0330 exhibits well characteri...
T72068 SFI003 Apoptosis , ROS
SFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen spec...
T9901A-004 Labetuzumab IMMU-14,hMN-14,IMMU-100
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
T77519 FC-116 FC116 Apoptosis , Microtubule Associated
FC-116 is a potent Tubulin inhibitor with antitumour activity and inhibits tumour growth in mice. FC-116 induces apoptosis in colorectal cancer (CRC) cells and promotes protein degradation.
T76890 Petosemtamab MCLA 158 EGFR
Petosemtamab (MCLA 158) is a highly potent monoclonal antibody against EGFR (Kd: 0.22 nM) and LGR5 (Kd: 0.86 nM). Petosemtamab promotes EGFR signaling disruption and receptor breakdown in LGR5+ cancer cells. Petosemtamab...
T9556 TNIK-IN-3 Wnt/beta-catenin
TNIK-IN-3 is a highly potent and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK). It exhibits a strong selectivity for TNIK with an IC50 value of 0.026 μM. Additionally, TNIK-IN-3 demonstrates...
T63049 CHD1Li 6.11 Others
CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM). CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenog...
T21567L Cyclosomatostatin Acetate Cyclosomatostatin Acetate (84211-54-1 Free base) Somatostatin
Cyclosomatostatin Acetate is an effective antagonist of the somatostatin receptor.Cyclosomatostatin Acetate inhibits SSTR1 signaling and decreases cell proliferation, ALDH+ cell population size, and sphere-formation in c...
T41180 JQAD1 Epigenetic Reader Domain
JQAD1 is a potent and selective histone acetyltransferase EP300 degrader (PROTAC®; DC50≤ 31.6 nM); comprises an EP300 inhibitor, A485, joined by a linker to a cereblon E3 ligase ligand. JQAD1 brings about degradation of ...
T4S1551 Cinnamaldehyde Cinnamic Aldehyde HIF
1. Cinnamaldehyde (Cinnamic Aldehyde) has antipyretic activity. 2. Cinnamaldehyde is a sedative agent. 3. Cinnamaldehyde inhibits invasive capabilities of MDA-MB-435S cells was correlated with down-regulating the express...
T27163 DHNQ
DHNQ is a novel inhibitor of the PI3K enzyme activity and transcriptional as well as translational expression levels in colorectal cancer (CRC).
T73391 BLM-IN-2
BLM-IN-2, a Bloom's Syndrome Protein (BLM) inhibitor, exhibits an IC50 of 0.8 μM and shows efficacy in suppressing proliferation, invasion, cell cycle arrest, and apoptosis in colorectal cancer (CRC) cells, making it a p...
1 2 3
TargetMol